A study on the ASAP nano-silver solution on pathogenic bacteria and candida

G. K. Bhat, E. Suman, A. Shetty, B. M. Hegde

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose: To study the effect of ASAP solution (10 ppm silver solution) on pathogenic bacteria and Candida albicans. Materials and methods: The bacteria studied included Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococcus faecalis, drug-resistant Escherichia coli, ESBL producing Klebsiella pneumoniae, drug-resistant Pseudomonas aeruginosa, Salmonella typhi, and Shigella flexneri. All bacteria were isolated from clinical samples. One strain of Candida albicans was also used. The inhibitory and microbicidal effect of ASAP were determined by broth dilution and suspension test. S. aureus ATCC 25,923 and E. coli ATCC 25,922 were used as controls. Results: ASAP solution inhibited and killed all bacteria and candida used in the study irrespective of the Gram reaction. Bacteria were more susceptible than candida. Contact time of 30 min - 60 min was needed to kill bacteria. C. albicans was killed after 120 min of exposure to ASAP. Conclusion: ASAP is effective in killing drug-resistant bacteria and C. albicans. This property of ASAP may be explored in the treatment of drug resistant infections.

Original languageEnglish
Pages (from-to)15-17
Number of pages3
JournalJournal, Indian Academy of Clinical Medicine
Volume10
Issue number1-2
Publication statusPublished - 01-2009

Fingerprint

Candida
Silver
Bacteria
Candida albicans
Pharmaceutical Preparations
Escherichia coli
Shigella flexneri
Salmonella typhi
Enterococcus faecalis
Klebsiella pneumoniae
Methicillin-Resistant Staphylococcus aureus
Pseudomonas aeruginosa
Staphylococcus aureus
Suspensions
Infection

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{0906c563b76241feb0b787f5f8199472,
title = "A study on the ASAP nano-silver solution on pathogenic bacteria and candida",
abstract = "Purpose: To study the effect of ASAP solution (10 ppm silver solution) on pathogenic bacteria and Candida albicans. Materials and methods: The bacteria studied included Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococcus faecalis, drug-resistant Escherichia coli, ESBL producing Klebsiella pneumoniae, drug-resistant Pseudomonas aeruginosa, Salmonella typhi, and Shigella flexneri. All bacteria were isolated from clinical samples. One strain of Candida albicans was also used. The inhibitory and microbicidal effect of ASAP were determined by broth dilution and suspension test. S. aureus ATCC 25,923 and E. coli ATCC 25,922 were used as controls. Results: ASAP solution inhibited and killed all bacteria and candida used in the study irrespective of the Gram reaction. Bacteria were more susceptible than candida. Contact time of 30 min - 60 min was needed to kill bacteria. C. albicans was killed after 120 min of exposure to ASAP. Conclusion: ASAP is effective in killing drug-resistant bacteria and C. albicans. This property of ASAP may be explored in the treatment of drug resistant infections.",
author = "Bhat, {G. K.} and E. Suman and A. Shetty and Hegde, {B. M.}",
year = "2009",
month = "1",
language = "English",
volume = "10",
pages = "15--17",
journal = "Journal, Indian Academy of Clinical Medicine",
issn = "0972-3560",
publisher = "Indian Academy of Clinical Medicine",
number = "1-2",

}

A study on the ASAP nano-silver solution on pathogenic bacteria and candida. / Bhat, G. K.; Suman, E.; Shetty, A.; Hegde, B. M.

In: Journal, Indian Academy of Clinical Medicine, Vol. 10, No. 1-2, 01.2009, p. 15-17.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A study on the ASAP nano-silver solution on pathogenic bacteria and candida

AU - Bhat, G. K.

AU - Suman, E.

AU - Shetty, A.

AU - Hegde, B. M.

PY - 2009/1

Y1 - 2009/1

N2 - Purpose: To study the effect of ASAP solution (10 ppm silver solution) on pathogenic bacteria and Candida albicans. Materials and methods: The bacteria studied included Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococcus faecalis, drug-resistant Escherichia coli, ESBL producing Klebsiella pneumoniae, drug-resistant Pseudomonas aeruginosa, Salmonella typhi, and Shigella flexneri. All bacteria were isolated from clinical samples. One strain of Candida albicans was also used. The inhibitory and microbicidal effect of ASAP were determined by broth dilution and suspension test. S. aureus ATCC 25,923 and E. coli ATCC 25,922 were used as controls. Results: ASAP solution inhibited and killed all bacteria and candida used in the study irrespective of the Gram reaction. Bacteria were more susceptible than candida. Contact time of 30 min - 60 min was needed to kill bacteria. C. albicans was killed after 120 min of exposure to ASAP. Conclusion: ASAP is effective in killing drug-resistant bacteria and C. albicans. This property of ASAP may be explored in the treatment of drug resistant infections.

AB - Purpose: To study the effect of ASAP solution (10 ppm silver solution) on pathogenic bacteria and Candida albicans. Materials and methods: The bacteria studied included Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococcus faecalis, drug-resistant Escherichia coli, ESBL producing Klebsiella pneumoniae, drug-resistant Pseudomonas aeruginosa, Salmonella typhi, and Shigella flexneri. All bacteria were isolated from clinical samples. One strain of Candida albicans was also used. The inhibitory and microbicidal effect of ASAP were determined by broth dilution and suspension test. S. aureus ATCC 25,923 and E. coli ATCC 25,922 were used as controls. Results: ASAP solution inhibited and killed all bacteria and candida used in the study irrespective of the Gram reaction. Bacteria were more susceptible than candida. Contact time of 30 min - 60 min was needed to kill bacteria. C. albicans was killed after 120 min of exposure to ASAP. Conclusion: ASAP is effective in killing drug-resistant bacteria and C. albicans. This property of ASAP may be explored in the treatment of drug resistant infections.

UR - http://www.scopus.com/inward/record.url?scp=67749147176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67749147176&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:67749147176

VL - 10

SP - 15

EP - 17

JO - Journal, Indian Academy of Clinical Medicine

JF - Journal, Indian Academy of Clinical Medicine

SN - 0972-3560

IS - 1-2

ER -